Triveni Bio
$115.0M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| June 18, 2025 | Later Stage VC (Series B) | $115.0M | N/A | - |
| October 26, 2023 | Early Stage VC (Series A) | $91.6M | N/A | - |
Current Valuation Metrics
Triveni Bio is currently valued at $310.0M as of June 18, 2025. The company has raised a total of $231.6M in funding across 2 funding rounds.
Capital Efficiency
With a capital efficiency ratio of 1.34x, Triveni Bio has achieved a valuation that is 1.34 times the total capital raised.
What is Triveni Bio Worth in 2026?
Triveni Bio is a leading private company in the Drug Discovery sector. Track Triveni Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Triveni Bio Valuation is Determined
Private company valuations like Triveni Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.